BDBM693815 N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-oxo-1,6-naphthyridin-7-yl]cyclopropanecarboxamide ::US20240287062, Compound 2

SMILES Cc1c(F)cncc1-c1cc2cnc(NC(=O)C3CC3)cc2n(C)c1=O

InChI Key InChIKey=INECKCAGMBSWRT-UHFFFAOYSA-N

Data  13 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 13 hits for monomerid = 693815   

TargetV299L(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 0.510nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetY253F(Human)
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 0.510nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetABL1(Human)
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 0.610nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetE255V(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 0.610nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetY253H(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 0.930nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetQ252H(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 1.20nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetH396P(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 1.20nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetM351T(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 1.5nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetG250E(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 1.5nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetE255K(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 2nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetF317L(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 17nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetF317I(Homo sapiens (Human))
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 47nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent

TargetT351I(Human)
Enliven

US Patent
LigandPNGBDBM693815(N-[3-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-2-ox...)
Affinity DataIC50: 4.40E+3nMAssay Description:Kinase activity of ABL1 was measured using the ADP-Glo system (Promega), which measures formation of ADP using a luminescence-based method. Compounds...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/12/2024
Entry Details
US Patent